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Objective: Although arteriovenous fistula is the best choice of vascular ac-
cess for hemodialysis, cuffed tunneled catheter widely used for hemodialysis
in the absence of arteriovenous fistula or arteriovenous graft fistula.
Indwelling a cuffed tunneled catheter in the central vein is a common
vascular access for hemodialysis. To some patients who can not lie down
due to heart failure or other reasons, catheterization through internal jugu-
lar vein may be exposed to an increased risk during catheterization proce-
dure. For these patients, catheterization through femoral vein may be a
good choice. In this study, we want to find the outcome of femoral vein cuf-
fed tunneled catheter for hemodialysis.
Methods: From April 2013 to December 2014, 32 maintained hemodialysis
patients received 34 cuffed tunneled catheters inserted through the femoral
vein. There were 15 male and 17 female patients. The patients’ mean age
was 73.46. A 45-cm-long Covidien double lumen catheter with a Dacron
cuff at 27 cm from the tip was placed in the femoral vein of each patient.
The tip of catheter was in the inferior vena cava.
Results: All procedures of femoral vein cuffed tunneled catheter implanta-
tion were technically successful. The 6-month primary patency rate was
62.8%. The 12-month primary patency rate was 51.3%. The 6-month assisted
primary patency rate was 83.5%. The 12-month assisted primary patency
rate was 62.2%. The blood flow of femoral vein catheter was 240 45 ml/
min. The mean session Kt/V was 1.37 0.36. The main complications were
1 thrombosis of femoral vein and external iliac vein, 2 stenosis of external
iliac vein, and 7 femoral vein catheter related bacteraemia (3.97 episodes
per 1000 CVC-days).
Conclusion: The femoral vein cuffed tunneled catheter could be used as a
vascular access for hemodialysis.http://dx.doi.org/10.1016/j.hkjn.2015.09.1840115
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Objective: Patients who undergo peritoneal dialysis (PD) often develop peri-
toneal fibrosis that is characterized by the accumulation of myofibroblasts,
but the precise origin of this fibrogenic cell type remains unknown. We
recently found that a-smooth muscle actin (a-SMA)+ myofibroblasts are co-
expressing CD68 macrophage antigen in the fibrotic peritoneum. Thus, we
hypothesized that macrophage-myofibroblast transition (MMT) may be a
novel source of myofibroblast origin during peritoneal fibrosis, which is
examined in this study.
Methods: Parietal peritoneal biopsy samples were collected from long-term
PD patients (nZ 10) and MMT cells were identified by CD68+a-SMA+ cells us-
ing two-color immunohistochemistry. LysM-Cre/Rosa26tdTomato mice were
constructed for macrophage fate mapping study in experimental PD model
induced by hyperglycemic dialysis solutions. Mechanisms of MMT were stud-
ied in vivo using Smad3 wildtype (WT) and knockout (KO) mice.
Results: Immunohistochemical study showed that a minor population of a-
SMA+ cells coexpressed CD68 in peritoneal biopsy tissues (5.08%). Immuno-
fluorescence and flow cytometry results demonstrated that > 90% CD68+
macrophages in peritoneal tissues were labeled with the tdTomato fate
marker in both control and model group. In addition, almost all tdTomato+
cells (> 99%) expressed with CD45 in model group, indicating that these
cells were recruited from bone marrow rather than resident macrophages.
Three-color confocal imaging showed that CD68+tdTomato+a-SMA+ cells
amounted to 9.39% of a-SMA+ myofibroblasts in model group and these cells
also expressed Collagen I. Compared to Smad3 WT littermates, the percent-
age of CD68+a-SMA+ cells was remarkably reduced in Smad3 KO model group
(p < 0.001).
Conclusion: Bone marrow-derived macrophages may constitute a novel
source of myofibroblasts during peritoneal fibrosis. Smad3 is required for
the MMT process.http://dx.doi.org/10.1016/j.hkjn.2015.09.185
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Objective: To study the relationship between body mass index (BMI) and
blood pressure (BP) control and their effect on cardiovascular mortality in
continuous ambulatory peritoneal dialysis (CAPD) patients.
Methods: We conduct a retrospective cohort study in 1144 incident CAPD
patients in our center to evaluate the association between BMI and BP con-
trol and their effect on cardiovascular mortality. The BMI was categorized
using the criteria from the Working Group on Obesity in China. Binary logis-
tic regression and the Cox’s proportional hazards regression models were
used to assess the relationship between BMI and uncontrolled BP, and the
association of BMI and uncontrolled BP with cardiovascular mortality,
respectively.
Results: The mean BMI was 21.74 3.17 kg/m2. Compared to patients with
normal weight, those with overweight were associated with an increased risk
of uncontrolled BP (OR, 1.93; 95% CI, 1.33e2.82), as well as uncontrolled SBP
(OR, 1.53; 95% CI, 1.06e2.22) in the full adjusted model. During a median
follow up of 26.6 months, 106 (9.3 %) patients died due to cardiovascular dis-
ease. Uncontrolled SBP was associated 96% higher risks of cardiovascular
death in adjusted model (OR, 1.96; 95% CI, 1.09e3.54). Although there
was no significant interaction between BMI and uncontrolled BP, individuals
with concurrent underweight and uncontrolled BP (HR, 3.07; 95% CI,
1.10e8.53), as well as underweight and uncontrolled SBP (HR, 4.60; 95%
